Application no. and date | 17758388.7 (espacenet) (Federated) (European Patent Register), 20170817 | Patent/reg. no. and date | DK/EP 3347352, 20190703 | Publication date | 20180718 | Priority no. and date | US 201662377312 P, 20160819, US 201762457555 P, 20170210 | EP pub. no. and date |
EP 3347352 20180718 | Effective date | | Applicant/owner | Gilead Sciences, Inc., 333 Lakeside Drive
Foster City, CA 94404, US | Applicant ref. no. | P68986DK01 | Inventor | GRAUPE, Michael, c/o Gilead Sciences Inc. 333 Lakeside Drive
Foster City, CA 94404, US, STEFANIDIS, Dimitrios, c/o Gilead Sciences Inc. 333 Lakeside Drive
Foster City, CA 94404, US, LINK, John O., c/o Gilead Sciences Inc. 333 Lakeside Drive
Foster City, CA 94404, US, ROWE, Charles William, c/o Gilead Sciences Inc. 333 Lakeside Drive
Foster City, CA 94404, US, SAITO, Roland D., c/o Gilead Sciences Inc. 333 Lakeside Drive
Foster City, CA 94404, US, SCHROEDER, Scott D., c/o Gilead Sciences Inc. 333 Lakeside Drive
Foster City, CA 94404, US, ZHANG, Jennifer R., c/o Gilead Sciences Inc. 333 Lakeside Drive
Foster City, CA 94404, US, HENRY, Steven J., 1111 West Hillsdale Blvd.
San Mateo, CA 94403, US, TSE, Winston C., 801 Windblown Lane
Redwood City, CA 94065, US | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | Opponent | | IPC Class | A61K 31/4439 (2006.01) , A61P 31/18 (2006.01) , C07D 401/14 (2006.01) | Title | TERAPEUTISKE FORBINDELSER ANVENDELIGE TIL PROFYLAKTISK ELLER TERAPEUTISK BEHANDLING AF EN HIV-VIRUSINFEKTION | Int. application no. | US2017047416 | Int. publication no. | WO2018035359 | Related patent (certificate) | CA 2022 00052 | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|